Literature DB >> 18684751

Prevalence and risk factors of retinal vein occlusion in an Asian population.

L L Lim1, N Cheung, J J Wang, F M A Islam, P Mitchell, S M Saw, T Aung, T Y Wong.   

Abstract

AIM: To describe the prevalence and risk factors of retinal vein occlusion (RVO) in an Asian population.
METHODS: The Singapore Malay Eye Study is a population-based, cross-sectional study of 3280 (78.7%) Malay adults (aged 40-80 years) living in Singapore. All participants underwent retinal photography, standardised interview, clinical examinations and laboratory investigations. RVO (central or branch) was graded based on the Blue Mountains Eye Study (BMES) protocol from retinal photographs.
RESULTS: The overall prevalence of RVO was 0.7% (n = 22) (95% CI 0.4 to 1.0) (18 branch and five central RVO cases). There was no significant gender difference in RVO prevalence. RVO was associated with higher systolic blood pressure (age-adjusted odds ratio (OR) per SD increase 1.54, CI 1.02 to 2.31), ocular perfusion pressure (OR per SD increase 1.49, CI 1.03 to 2.16), a history of angina (OR 5.18, CI 1.49 to 18.0) and heart attack (OR 4.26, CI 1.47 to 12.3), and higher total cholesterol (OR per SD increase 1.55, CI 1.07 to 2.24) and LDL (OR per SD increase 1.47, CI 1.02 to 2.12) cholesterol levels.
CONCLUSIONS: The prevalence of RVO in this Asian population was lower than Caucasians in the BMES, although the systemic associations of RVO were largely similar to BMES and other studies.

Entities:  

Mesh:

Year:  2008        PMID: 18684751     DOI: 10.1136/bjo.2008.140640

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  34 in total

1.  Recurrence of macular edema in eyes with branch retinal vein occlusion changes the diameter of unaffected retinal vessels.

Authors:  Jong Chan Im; Jae Pil Shin; In Taek Kim; Dong Ho Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-18       Impact factor: 3.117

2.  Predictive factors for recurrence of macular edema after successful intravitreal bevacizumab therapy in branch retinal vein occlusion.

Authors:  Rika Yamada; Akihiro Nishida; Masataka Shimozono; Takanori Kameda; Noriko Miyamoto; Michiko Mandai; Yasuo Kurimoto
Journal:  Jpn J Ophthalmol       Date:  2015-09-03       Impact factor: 2.447

3.  Branch retinal vein occlusion: the importance of the topographical distribution of retinal vessels among risk factors.

Authors:  Z Oztas; C Akkin; S Nalcaci; O Ilim; F Afrashi
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

4.  Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan.

Authors:  Paula Anne Newman-Casey; Maxwell Stem; Nidhi Talwar; David C Musch; Cagri G Besirli; Joshua D Stein
Journal:  Ophthalmology       Date:  2014-06-20       Impact factor: 12.079

5.  Relationship between metamorphopsia and foveal microstructure in patients with branch retinal vein occlusion and cystoid macular edema.

Authors:  Tomoya Murakami; Fumiki Okamoto; Masaharu Iida; Yoshimi Sugiura; Yoshifumi Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-12       Impact factor: 3.117

6.  The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia.

Authors:  Sophie Rogers; Rachel L McIntosh; Ning Cheung; Lyndell Lim; Jie Jin Wang; Paul Mitchell; Jonathan W Kowalski; Hiep Nguyen; Tien Y Wong
Journal:  Ophthalmology       Date:  2010-02       Impact factor: 12.079

7.  Effect of Fufang Xueshuantong Capsule on a rat model of retinal vein occlusion.

Authors:  Yuan-Zhi Yuan; Fei Yuan; Qin-Yue Xu; Jia Yu; Lei Li; Ju-Li Zhang
Journal:  Chin J Integr Med       Date:  2011-04-21       Impact factor: 1.978

Review 8.  The burden of disease of retinal vein occlusion: review of the literature.

Authors:  M Laouri; E Chen; M Looman; M Gallagher
Journal:  Eye (Lond)       Date:  2011-05-06       Impact factor: 3.775

9.  Improved visual outcome with early treatment in macular edema secondary to retinal vein occlusions: 6-month results of a Korean RVO study.

Authors:  Young Hee Yoon; Ha Kyoung Kim; Hee Seong Yoon; Se Woong Kang; June-Gone Kim; Kyu Hyung Park; Young Joon Jo; Joo Yong Lee; Dong Hoon Lee
Journal:  Jpn J Ophthalmol       Date:  2014-01-31       Impact factor: 2.447

10.  10-year fundus tessellation progression and retinal vein occlusion.

Authors:  Yan-Ni Yan; Ya-Xing Wang; Yan Yang; Liang Xu; Jie Xu; Qian Wang; Jing-Yan Yang; Wen-Jia Zhou; Wen-Bin Wei; Jost B Jonas
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.